Memorial Sloan Kettering Cancer Center

A new study from Anthony Yu, Chau Dang, and @JLiu_MSKCardOnc evaluated the cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted treatment. @MSKCancerCenter @JACCJournals #cancer jacc.org/doi/10.1016/j.…

After one patient's synovial sarcoma returned, a clinical trial led MSK helped shrink his tumors by 85%. That same #Tcell therapy is now approved by the @US_FDA. “This success story is just one example of MSK’s innovative approach to researching new treatments,” says MSK's…

We want to hear from you! Now through 7/31, take a short survey to share your feedback that will help MSK identify key health needs and improve programs in our communities. Access the survey here: bit.ly/4n6meit

Join us @MSKCancerCenter or virtually for a state-of-the-art, interdisciplinary update on key topics related to the care of cancer patients with #pulmonary comorbidities and complications arising from cancer and its treatments. Early discounted rates are available through August…

🚨Today, in @NatureCancer, we show that CAR-T cells and CAR-NK cells contain the seeds of their own self-destruction. Disruption of a FAS-L/FAS circuit enhances CAR potency against liquid and solid cancers. rdcu.be/exjEy @MSKCancerCenter @parkerici @MSK_DeptOfMed

“Metastasis used to be an automatic death sentence, but that is no longer the case,” says Dr. Joan Massagué, Chief Scientific Officer at MSK. At @AACR's 2025 Annual Meeting, he presented emerging insights into the biology of #metastasis and their potential to inform future…

Published in @NatureSMB: Q&A with MSK's @Yael_David__ and Dr. Charles Rice of @RockefellerUniv on their recent publication about using #chromatin biology to understand #hepatitisB. ⬇️ nature.com/articles/s4159…

Join us for an insightful webinar on liver mets & HAI pump therapy with Dr. Louise Connell from @MSKCancerCenter and stage IV survivor @ctycka. Discover how HAI therapy can be a game-changer for patients. Register now: fightcrc.zoom.us/webinar/regist… TY @InteraOncology for your support!

Wonderful opportunity sharing #BestofASCO 2025 highlights in Multiple Myeloma. How to (and not to) apply recent trial data in clinical practice. Some great talks on Leukemia, Lymphoma. #MMSM #CART #ASCODirect #ASCO25 #MedTwitter #MedEd @TotalHealthConf @ASCO @MSKCancerCenter

Big day for the David lab! 🎉 Our @MolecularCell paper is out today- huge congrats to first authors @IfeAkano & Jake Hebert for leading this beautiful study uncovering SMARCA3 as a novel H3 E3 ligase that shapes heterochromatin regulation in colorectal cancer 🤩

🚨 New research led by MSK's Dr. Andrew McPherson, @SohrabShah & team reveals how whole-genome doubling (WGD) helps #ovariancancer tumors adapt and be more resistant to treatment. The study, which was published in @Nature, found that over 65% of ovarian cancer tumors showed high…

That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn @MSKCancerCenter

Congratulations @MSKCancerCenter, @JonesDavid2013, & Dr. Jamie Chaft for opening one of the latest TSOG-supported studies, TROPION-Lung12! #NSCLC @MSK_Thoracic

#KCRSR25 Rapid Abstract: Doris Zheng @MSKCancerCenter will show how RCC behaves differently in male vs female mouse models, revealing immune and metastatic patterns that mirror human disease. Read all the abstracts: bit.ly/AbstractsKCRS25 Register: bit.ly/RegisterKCRS25…

MSK researchers are advancing the standard of care for treating head and neck cancers, including #thyroidcancer. Recent work highlights progress in areas such as active surveillance, identification of mutation profiles, #redifferentiation therapy, and more:…

We're pleased to announce that early registration is now open for the 2025 Thoracic Pathology Course. Co-sponsored by @MSKCancerCenter and @MassGeneralNews, and endorsed by the @PulmPathSoc, this course offers a comprehensive review of thoracic #pathology with clinical and…

New research from MSK investigates whether introducing new mutations could make #immunotherapy more effective against some cancers; shows that people in their 90s who underwent #lungcancer surgery had positive outcomes; shares lessons on the responsible governance of #AI in…

🫁 Check out our #ASCO25 interview with Shriya Garg of the University of Georgia and @EChrisDee of @MSKCancerCenter, covering their research on palliative intent lung cancer disparities in disaggregated Hispanic patient populations! ➡️ Learn more: buff.ly/z4glqqv #lcsm

🎉 Today we welcome the 2025 cohort of #Postbac MSK Bridge Scholars! We’re thrilled to have them join us for the next 2 years of #biomedical #research training and educational support. RT to help us give a warm welcome to our #MSKBridge Scholars! 🙌

Dr. Ghassan Abou-Alfa is a renowned medical oncologist at @MSKCancerCenter. Here, he discusses the impact of cholangiocarcinoma and the role of the CCA Summit in driving research, collaboration, and improved patient care: bit.ly/4dvhGOl #CancerCare #OncologyInnovations